ArticleClinical rheumatology2022
Low dosage use of cyclophosphamide improves the survival of patients with systemic lupus erythematosus.
Yoosuf Ali Ashraf Muhammad Hussenbocus et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it